Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23174910)

1.

Cigarette smoke condensate induces differential expression and promoter methylation profiles of critical genes involved in lung cancer in NL-20 lung cells in vitro: short-term and chronic exposure.

Word B, Lyn-Cook LE Jr, Mwamba B, Wang H, Lyn-Cook B, Hammons G.

Int J Toxicol. 2013 Jan-Feb;32(1):23-31. doi: 10.1177/1091581812465902. Epub 2012 Nov 21.

PMID:
23174910
2.

Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.

Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S.

Clin Cancer Res. 2005 Apr 1;11(7):2466-70.

3.

Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.

Yuregir OO, Yurtcu E, Kizilkilic E, Kocer NE, Ozdogu H, Sahin FI.

Int J Lab Hematol. 2010 Apr;32(2):142-9. doi: 10.1111/j.1751-553X.2009.01146.x. Epub 2009 Mar 2.

PMID:
19302404
4.

Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.

Kontic M, Stojsic J, Jovanovic D, Bunjevacki V, Ognjanovic S, Kuriger J, Puumala S, Nelson HH.

Clin Lung Cancer. 2012 Jul;13(4):297-303. doi: 10.1016/j.cllc.2011.11.003. Epub 2011 Dec 13.

5.

Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure.

Scesnaite A, Jarmalaite S, Mutanen P, Anttila S, Nyberg F, Benhamou S, Boffetta P, Husgafvel-Pursiainen K.

Mutagenesis. 2012 Jul;27(4):423-9. doi: 10.1093/mutage/ger092. Epub 2012 Jan 4.

6.

Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.

Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.

PMID:
19695681
7.
8.

PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.

Buckingham L, Penfield Faber L, Kim A, Liptay M, Barger C, Basu S, Fidler M, Walters K, Bonomi P, Coon J.

Int J Cancer. 2010 Apr 1;126(7):1630-9. doi: 10.1002/ijc.24896.

PMID:
19795445
9.
10.

Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.

Hoffmann AC, Kaifi JT, Vallböhmer D, Yekebas E, Grimminger P, Leers JM, Izbicki JR, Hölscher AH, Schneider PM, Metzger R, Brabender J.

J Surg Oncol. 2009 Oct 1;100(5):414-7. doi: 10.1002/jso.21348.

PMID:
19653236
11.

Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion.

Katayama H, Hiraki A, Aoe K, Fujiwara K, Matsuo K, Maeda T, Murakami T, Toyooka S, Sugi K, Ueoka H, Tanimoto M.

Int J Cancer. 2007 May 15;120(10):2191-5.

PMID:
17285579
12.

Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.

Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H.

Ann Surg Oncol. 2008 Nov;15(11):3272-7. doi: 10.1245/s10434-008-0078-9. Epub 2008 Aug 20.

PMID:
18712569
13.
14.

Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.

Divine KK, Pulling LC, Marron-Terada PG, Liechty KC, Kang T, Schwartz AG, Bocklage TJ, Coons TA, Gilliland FD, Belinsky SA.

Int J Cancer. 2005 Apr 10;114(3):400-5.

PMID:
15578700
15.

Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.

Su Y, Xu H, Xu Y, Yu J, Xian Y, Luo Q.

Hematology. 2012 Jan;17(1):41-6. doi: 10.1179/102453312X13221316477624.

PMID:
22549447
16.
17.

Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.

Iliopoulos D, Oikonomou P, Messinis I, Tsezou A.

Oncol Rep. 2009 Jul;22(1):199-204.

PMID:
19513524
18.

Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).

Niklinska W, Naumnik W, Sulewska A, Kozłowski M, Pankiewicz W, Milewski R.

Folia Histochem Cytobiol. 2009;47(2):275-80. doi: 10.2478/v10042-009-0091-2.

19.

Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.

Rastetter M, Schagdarsurengin U, Lahtz C, Fiedler E, Marsch WCh, Dammann R, Helmbold P.

Histol Histopathol. 2007 Sep;22(9):1005-15.

PMID:
17523078
20.

Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.

Liu Y, Gao W, Siegfried JM, Weissfeld JL, Luketich JD, Keohavong P.

BMC Cancer. 2007 May 3;7:74.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk